Despite GALNT16 being classified as an N‐acetylgalactosaminyltransferase, previous studies have implicated it in protein and lipid metabolism, as well as in AMPK, prolactin, and insulin/IGF signaling pathways, and it may also play a role in lipid metabolism associated with cardiovascular diseases. The gene discussed is PRL; the disease is cardiovascular disorder.